Clinical trials sponsored by University of Calgary

Phase breakdown

Conditions studied

Recruiting trials led by University of Calgary

• Adaptation and Pilot Testing of Web and Mobile Interface for the ATTACH™ Intervention
  NCT04857775 · Phase: Not applicable (e.g. observational or device study) · Ages: No age limits stated · Sex: All (male and female) · 1 location
• Aerobic Exercise for Older Adults at Increased Risk of Alzheimer's Disease and Related Dementias
  NCT03035851 · Phase: Not applicable (e.g. observational or device study) · Ages: 50 Years to 80 Years · Sex: All (male and female) · 1 location
• Assessing Systemic Circulation and LV Performance in Adults
  NCT04347655 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Brain STimulation for ANxiety and Depression in Youth
  NCT06892847 · Phase: Not applicable (e.g. observational or device study) · Ages: 6 Years to 18 Years · Sex: All (male and female) · 1 location
• Building Emotional Awareness and Mental Health in Parenting (BEAM)
  NCT06046989 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 65 Years · Sex: All (male and female) · 4 locations
• Cannabis for the Prophylactic Treatment of Migraine
  NCT03972124 · Phase: Phase 2 · Ages: 25 Years and older · Sex: All (male and female) · 1 location
• EXCEL: Exercise for Cancer to Enhance Living Well
  NCT04478851 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 100 Years · Sex: All (male and female) · 6 locations
• Feasibility and Pilot Testing of "My Heart and CKD" Online Shared Decision Aid
  NCT06920927 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Finding Alternatives to Standard Treatment for Attention-Deficit Hyperactivity Disorder
  NCT04532190 · Phase: Not applicable (e.g. observational or device study) · Ages: 9 Years to 15 Years · Sex: All (male and female) · 1 location
• Implementation of an App-based Walking Aid Skills Training Program
  NCT05347875 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 99 Years · Sex: All (male and female) · 2 locations
• Improving Sleep to Prevent Depression & Anxiety in Adolescents at High Risk
  NCT06358495 · Phase: Not applicable (e.g. observational or device study) · Ages: 12 Years to 18 Years · Sex: All (male and female) · 1 location
• Investigating Health, Equity, and Resilience in Girls and Women With ADHD Across the Lifespan
  NCT07597707 · Phase: Not specified · Ages: 10 Years and older · Sex: Female · 1 location
• Nonmyeloablative Stem Cell Transplant in Children With Sickle Cell Disease and a Major ABO-Incompatible Matched Sibling Donor
  NCT03214354 · Phase: Phase 2 · Ages: 1 Year to 19 Years · Sex: All (male and female) · 1 location
• PATHFINDER: Evaluating the Optimal First-Line Treatment Strategy for Moderate-to-Severely Active Ileal-dominant Crohn's Disease
  NCT05928039 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 20 locations
• PROMIS and Mobility Evaluation in Sarcoma Patients
  NCT07227961 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 4 locations
• Pharmacogenetic-Guided Antidepressant Prescribing in Adolescents With Anxiety and Depression
  NCT06853587 · Phase: Not applicable (e.g. observational or device study) · Ages: 12 Years to 17 Years · Sex: All (male and female) · 1 location
• Pharmacogenomics of Stimulant Treatment Response
  NCT06221358 · Phase: Not specified · Ages: 6 Years to 24 Years · Sex: All (male and female) · 1 location
• RAPID AFib Decision Aid for Stroke Prevention in Atrial Fibrillation
  NCT05900414 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Sustainable Implementation of the EXCEL Exercise Oncology Program Across Canada
  NCT06960291 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 15 locations
• Ultrasound and Proteomics for Guselkumab Response Assessment in Crohn's Disease (UPGRADE).
  NCT07246460 · Phase: Not specified · Ages: Up to 80 Years · Sex: All (male and female) · 1 location
• iTBS+D-Cycloserine for Youth Suicide
  NCT06121284 · Phase: Phase 2 · Ages: 18 Years to 24 Years · Sex: All (male and female) · 1 location

Common questions

How many trials is University of Calgary recruiting for?

University of Calgary is the lead sponsor of 21 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.